Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
3/6 We share the concerns about how these drugs are being used and whether the REMS program is working as intended. That was an impetus for the AdCom. We’re carefully examining TIRF prescribing to non-opioid-tolerant or non-cancer patients, and adverse outcomes like overdose.
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.